You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenovirus Infections, Human

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenovirus Infections in Allogenic Hematopoietic Cell Transplant

Completed
  • Adenovirus Infections, Human
    • (no location specified)
    Mar 10, 2022

    Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

    Enrolling by invitation
    • Malignant Melanomas
    • Recombinant Human Adenovirus Type 5 Injection
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
    Jul 7, 2023

    Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

    Recruiting
    • Malignant Pleural Mesothelioma, Advanced
    • Oncolytic Adenovirus H101
    • Programmed death receptor-1 inhibitor
    • Tianjin, Tianjin, China
      Tianjin Medical Unversity Second Hospital
    Sep 2, 2023

    Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

    Not yet recruiting
    • Malignant Melanoma
    • Liver Metastases
    • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
    • (no location specified)
    Dec 23, 2022

    Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)

    Completed
    Has Results
    • Human Immunodeficiency Virus
    • Ad26.Mos.HIV
    • +2 more
    • Bangkok, Thailand
      (unnamed)
    Dec 29, 2021

    Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)

    Recruiting
    • Adenovirus Infection
    • Adenovirus Specific T lymphocytes
    • Columbus, Ohio
      Nationwide Children's Hospital
    Sep 1, 2022

    Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

    Not yet recruiting
    • Adenovirus
    • +2 more
    • Specific T- Lymphocytes
    • Pittsburgh, Pennsylvania
      UPMC Children's Hospital of Pittsburgh
    Sep 8, 2023

    Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)

    Not yet recruiting
    • Primary Hepatocellular Carcinoma
    • Portal Vein Thrombosis
    • Recombinant human adenovirus type 5 + TACE
    • (no location specified)
    May 14, 2023

    Cytomegalovirus, Adenovirus Trial in Memphis (VST infusion, CliniMACS)

    Not yet recruiting
    • Cytomegalovirus
    • Adenovirus
    • VST infusion
    • CliniMACS
    • Memphis, Tennessee
      St . Jude Children's Research Hospital
    Jan 9, 2023

    Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)

    Not yet recruiting
    • Cholangiocarcinoma, Intrahepatic
    • Recombinant Human Adenovirus Type 5
    • HAIC of FOLFOX
    • Beijing, Beijing, China
      Beijing Tsinghua Chang Gung Hospital
    Mar 16, 2022

    Human Papillomavirus Infections Trial in Belgium, United States (Ad26.HPV16, Ad26.HPV18, MVA.HPV16/18)

    Terminated
    Has Results
    • Human Papillomavirus Infections
    • Ad26.HPV16
    • +3 more
    • Doral, Florida
    • +11 more
    Nov 23, 2021

    HPV Infection, CIN1 Trial in Belgium, Estonia, United Kingdom (ChAdOx1-HPV, MVA-HPV, Placebo)

    Active, not recruiting
    • HPV Infection
    • CIN1
    • ChAdOx1-HPV
    • +2 more
    • Antwerp, Belgium
    • +15 more
    Jan 9, 2023

    Viral Infections After HSCT Trial in Washington (VSTs)

    Active, not recruiting
    • Viral Infections After HSCT
    • VSTs
    • Washington, District of Columbia
      Childrens National Medical Center
    Aug 30, 2022

    Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

    Recruiting
    • Untreated Advanced Non-small Cell Lung Cancer
    • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital
    Nov 13, 2023

    Epstein-Barr Virus Infections, Cytomegalovirus Infections, Adenovirus Trial in New York (Rapidly generated virus specific T

    Not yet recruiting
    • Epstein-Barr Virus Infections
    • +3 more
    • Rapidly generated virus specific T (R-MVST) cells
    • New York, New York
      Columbia University Irving Medical Center
    Feb 18, 2022

    Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

    Recruiting
    • Adenovirus Infection
    • +6 more
    • Virus-specific Cytotoxic T-lymphocytes
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 6, 2023

    Bladder Cancer Trial in Hangzhou (H101, Camrelizumab)

    Recruiting
    • Bladder Cancer
    • H101, Camrelizumab
    • Hangzhou, Zhejiang, China
      Hua Wang
    Oct 2, 2022

    Hepatocellular Carcinoma Trial in Xi'an (Recombinant Human Adenovirus Type 5 injection, Sorafenib)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Recombinant Human Adenovirus Type 5 injection
    • Sorafenib
    • Xi'an, Shaanxi, China
    • +3 more
    Jan 25, 2022

    Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

    Recruiting
    • Adenovirus
    • Primary Immune Deficiency Disorder
    • cytotoxic t-lymphocytes
    • Los Angeles, California
    • +8 more
    Sep 27, 2022

    Advanced/Metastatic Solid Tumours Trial in Canada (MG1MA3, AdMA3)

    Active, not recruiting
    • Advanced/Metastatic Solid Tumours
    • MG1MA3
    • AdMA3
    • Vancouver, British Columbia, Canada
    • +3 more
    Jan 30, 2023

    Adenovirus Type-5 Vectored COVID-19 Vaccine Trial in Wuhan (Adenovirus Type-5 Vectored COVID-19 Vaccine)

    Completed
    • Adenovirus Type-5 Vectored COVID-19 Vaccine
    • Adenovirus Type-5 Vectored COVID-19 Vaccine
    • Wuhan, Hubei, China
      A rehabilitation centre in Wuhan
    Mar 28, 2022

    Adenovirus Infection, BK Virus Infection, Cytomegalovirus Infections Trial in Worldwide (Posoleucel (ALVR105), Placebo)

    Recruiting
    • Adenovirus Infection
    • +5 more
    • Posoleucel (ALVR105)
    • Placebo
    • Birmingham, Alabama
    • +60 more
    Mar 30, 2022

    Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

    Recruiting
    • Head and Neck Cancer
    • +6 more
    • Recombinant L-IFN adenovirus injection
    • Shanghai, Shanghai, China
      Shanghai Fengxian District Central Hospital
    Jan 16, 2022

    Adenovirus Infection Trial in United States (BCV)

    Recruiting
    • Adenovirus Infection
    • Los Angeles, California
    • +10 more
    May 24, 2022

    Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization Trial

    Recruiting
    • Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
    • Recombinant adenovirus type-5-vectored COVID-19 vaccine
    • Hangzhou, Zhejiang, China
      Xihu District Center for Disease Control and Prevention
    May 12, 2022